Halter Ferguson Financial Inc.: Significant Purchases & Sales Observed in Q2 2026 Portfolio
Halter Ferguson Financial Inc.'s portfolio analysis for Q2 2026 reveals substantial buying activity, particularly in LMND and UPST, alongside notable selling of high-profile tech stocks like MU.
Quarterly Portfolio Shifts at Halter Ferguson Financial Inc.
Halter Ferguson Financial Inc.'s portfolio filing for the period ending June 30, 2026 (view report), shows a dynamic shift in holdings. The firm's total portfolio value stands at $564 million.
The most striking change involves LMND (Lemonade Inc.). This Financial Services stock saw an unprecedented 84.11% increase in shares held during the quarter, representing a significant new position or substantial addition to an existing one. The firm now holds approximately 10.65% of its portfolio in LMND.
Alongside this massive stake in Lemonade Inc., Halter Ferguson Financial also significantly increased its position in UPST (Upstart Holdings), boosting the allocation by nearly 20 percentage points to about 10.08%. This suggests strong confidence in these financial services companies.
New positions were initiated with BLZE (Backblaze Inc.). The firm purchased shares of this Technology company, increasing its stake from zero to a new allocation of roughly 1.18%, indicating potential interest in the cloud storage sector.
The buying activity wasn't limited to tech and finance; OSCR (Oscar Health Inc.) also experienced substantial growth with a nearly 55% increase in shares, adding about 0.4 percentage points to its portfolio allocation of around 2.91%. This further diversifies the firm's holdings into Healthcare.
In contrast, Halter Ferguson Financial divested from several high-profile Technology stocks this quarter. MU (Micron Technology) saw a drastic reduction in shares held by approximately 72%, leading to its exit or near-exit from the portfolio.
The firm also sold off significant portions of other Technology holdings, including NVDA (NVIDIA Corporation), which experienced an almost 74% decrease. Additionally, substantial sales were noted in GOOGL and PLTR, though their allocations remain relatively small compared to the largest positions.
While not a complete exit, there was also a moderate reduction of about 15% in shares held for CADL (Candel Therapeutics), impacting its portfolio allocation slightly. These changes highlight an active management approach focused on performance and risk assessment.